Research Solutions, Inc.
(OTCQB:RSSS)

Research Solutions, Inc. (RSSS)

Research Solutions Engages Liolios Group to Lead New Strategic Investor Relations Program

Sep 22, 2014

ENCINO, Calif., Sept. 22, 2014 /PRNewswire/ -- Research Solutions, Inc. (OTCQB: RSSS), a pioneer in facilitating the flow of information from publishers of scientific, technical and medical (STM) content to life science enterprises and other research organizations, has engaged Liolios Group to lead a new strategic investor relations and financial communications program.

"Today marks an important milestone at Research Solutions with the divestiture of our TAAG printing and logistics subsidiary," said Research Solutions President and CEO Peter Derycz. "It represents a major step in our transition from a hybrid digital-print business to a fully digital solution that improves the flow of high-value STM information. Article Galaxy, our cloud-based software-as-a-service (SaaS) solution, is experiencing an explosive adoption rate and quickly becoming an industry standard as the 'Bloomberg' of science and technology. The acceleration in Article Galaxy subscriptions puts us on track to profitability in fiscal 2015."

"Given the transformation in our business and strengthened balance sheet, we believe our shareholders would benefit from an experienced team of financial communication professionals to reintroduce Research Solutions to the investment community," continued Derycz. "Liolios Group brings to Research Solutions a proven track record of helping SaaS solution companies like ours enhance shareholder value by delivering the right message to the right audience, and by establishing high-quality, long-term relationships with analysts and other influential members of the financial community."

Over the course of the next several weeks, Liolios Group will work closely with Research Solutions management to develop and deploy a comprehensive capital markets strategy and campaign. Activities will include delivering effective messaging and corporate positioning, strategic advisory, and introductions to analysts, institutional investors and other key influencers. Liolios Group will also assist in scheduling road shows and financial conferences for management over the next several months.

For additional information about Research Solutions, contact Liolios Group at +1 (949) 574-3860 or email RSSS@liolios.com.

About Liolios Group

Liolios Group, Inc. is a highly selective and comprehensive investor relations firm specializing in small-cap companies. The firm aims to deliver superior performance in corporate messaging and positioning, investor awareness, analyst and financial press coverage, and capital attraction. Founded in 1999, Liolios Group executives have extensive experience in finance and investments, and represent clients in a wide range of industries, including technology, digital media, consumer/internet retail, healthcare/life sciences, natural resources and business services. For more information about Liolios Group, please visit www.liolios.com.       

About Research Solutions

Research Solutions, Inc. (OTCQB:RSSS) and its wholly-owned subsidiary Reprints Desk, Inc. (www.reprintsdesk.com) are pioneers in facilitating the flow of information from the publishers of scientific, technical, and medical (STM) content to enterprise customers in life science and other research intensive organizations. Our customers include 70% of the top 25 pharma companies in the world. Our cloud based software-as-a-service (SaaS) solution, Article Galaxy, provides customers with access to hundreds of thousands of newly published articles each year in addition to the tens of millions of existing articles that have been published in the past, helping them to identify the content that is critical to their research. We have arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, we also serve STM publishers by facilitating compliance with applicable copyright laws.

About Reprints Desk®

Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in the every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008.

Forward-Looking Statements         

Certain matters discussed in this press release may be forward-looking statements.  Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q.  Examples of forward-looking statements in this release include statements related to our new strategic focus, product verticals, anticipated revenue and profitability.  The Company assumes no obligation to update the cautionary information in this release.

SOURCE Research Solutions, Inc.

For further information: Media, Research Solutions, Inc., Ian Palmer, Chief Sales and Marketing Officer, 818-259-1701, ipalmer@reprintsdesk.com, or Investors, Liolios Group, Inc., Chris Tyson, 949-574-3860, RSSS@liolios.com


Print Email RSS
print email rss